Routine symptom assessment: good for practice and good for business

E. Bruera

DOI: https://doi.org/10.1007/s00520-008-0433-1

IF: 3.1

2008-04-02

Supportive Care in Cancer

Abstract:

What problem does this paper attempt to address?

An Insight into COVID-19 and Traditional Herbs: Bangladesh Perspective

Abdur Rauf,Md. Mominur Rahman,Sheikh Shohag,Md. Rezaul Islam,Shomaya Akhter,Sadia Afsana Mim,Rohit Sharma

DOI: https://doi.org/10.2174/1573406418666220829144746

2023-02-08

Medicinal Chemistry

Abstract:SARS-CoV-2 was first discovered in Wuhan in late 2019 and has since spread over the world, resulting in the present epidemic. Because targeted therapeutics are unavailable, scientists have the opportunity to discover new drugs or vaccines to counter COVID-19, and therefore a number of synthetic bioactive compounds are now being tested in clinical studies. Due to its broad therapeutic spectrum and low adverse effects, medicinal herbs have been used as traditional healing medication in those countries for ages. Due to a lack of synthetic bioactive antiviral medications, pharmaceutical and alternative therapies have been developed using a variety of herbal compositions. Due to the widespread availability of herbal and dietary products worldwide, people frequently use them. Notably, the majority of Bangladeshi people continue to use a variety of natural plants and herbs to treat various types of diseases. This review discusses how previous research has shown that some herbs in Bangladesh have immunomodulatory and antiviral effects and how their active ingredients have been gathered. Even though FDA-approved medications and vaccines are available for the treatment of Covid- 19, the purpose is to encourage the use of herbal medicine as immunomodulators and vaccine adjuvants for the treatment of COVID-19 prevention.

chemistry, medicinal
Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research

Sayeed Ahmad,Sultan Zahiruddin,Bushra Parveen,Parakh Basist,Abida Parveen,Gaurav,Rabea Parveen,Minhaj Ahmad

DOI: https://doi.org/10.3389/fphar.2020.578970

IF: 5.6

2021-03-02

Frontiers in Pharmacology

Abstract:The cases of COVID-19 are still increasing day-by-day worldwide, even after a year of its first occurrence in Wuhan city of China. The spreading of SARS-CoV-2 infection is very fast and different from other SARS-CoV infections possibly due to structural differences in S proteins. The patients with severe diseases may die due to acute respiratory distress syndrome (ARDS) caused by systemic inflammatory reactions due to the excessive release of pro-inflammatory cytokines and chemokines by the immune effector cells. In India too, it is spreading very rapidly, although the case fatality rate is below 1.50% ( https://www.statista.com ), which is markedly less than in other countries, despite the dense population and minimal health infrastructure in rural areas. This may be due to the routine use of many immunomodulator medicinal plants and traditional AYUSH formulations by the Indian people. This communication reviews the AYUSH recommended formulations and their ingredients, routinely used medicinal plants and formulations by Indian population as well as other promising Indian medicinal plants, which can be tested against COVID-19. Special emphasis is placed on Indian medicinal plants reported for antiviral, immunomodulatory and anti-allergic/anti-inflammatory activities and they are categorized for prioritization in research on the basis of earlier reports. The traditional AYUSH medicines currently under clinical trials against COVID-19 are also discussed as well as furtherance of pre-clinical and clinical testing of the potential traditional medicines against COVID-19 and SARS-CoV-2. The results of the clinical studies on AYUSH drugs will guide the policymakers from the AYUSH systems of medicines to maneuver their policies for public health, provide information to the global scientific community and could form a platform for collaborative studies at national and global levels. It is thereby suggested that promising AYUSH formulations and Indian medicinal plants must be investigated on a priority basis to solve the current crisis.

pharmacology & pharmacy
Exploration of medicinal plants as potential therapeutics against COVID-19: molecular insights and drug development prospects with other significant medicinal information a retrospective exposition

Saurabh Dilip Bhandare

DOI: https://doi.org/10.1093/jpp/rgae074

2024-08-21

Abstract:Objectives: The study aims to explore the potential of medicinal plants and their phytoconstituents as effective inhibitors of the coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus. The focus is on investigating specific medicinal plants known for their pharmacological properties, such as: antioxidant, anti-inflammatory, and immunomodulatory effects, to determine their viability in developing COVID-19 treatments. Materials and methods: This study involves a comprehensive study of medicinal plants, including: Withania somnifera (Ashwagandha) and Ocimum sanctum (Holy Basil), known for their beneficial health effects. Molecular docking studies were conducted to assess the interactions between phytoconstituents from these plants and SARS-CoV-2 proteins. The compounds' drug-like characteristics and safety profiles were also evaluated to determine their potential as therapeutic agents. Results: The molecular docking studies revealed that the phytoconstituents from the studied medicinal plants exhibit favourable interactions with SARS-CoV-2 proteins, suggesting their potential as therapeutic targets. These compounds demonstrated promising drug-like characteristics and safety profiles, indicating their suitability for further development as COVID-19-fighting medications. Discussion: The results indicate that medicinal plants and their bioactive substances hold significant potential for developing therapies against COVID-19. The ability of these organic substances to interact with key viral proteins and provide various therapeutic benefits highlights their potential as multi-functional treatment options. However, further research is necessary to confirm these findings and to understand the full scope of their therapeutic efficacy and safety in clinical settings. Conclusions: Medicinal plants and their phyto-constituents represent a promising avenue for developing effective treatments for COVID-19. The favourable interactions with SARS-CoV-2 proteins and the promising drug-like characteristics observed in this study suggest that these natural compounds could be integral in the fight against the COVID-19 pandemic. Further research and clinical trials are essential to fully validating their potential and translating these findings into practical medical applications.
Medicinal plants used in Gabon for prophylaxis and treatment against COVID-19-related symptoms: an ethnobotanical survey

Marlaine Michel Boukandou Mounanga,Annais Mezui,Ludovic Mewono,Jean Bertrand Mogangué,Sophie Aboughe Angone

DOI: https://doi.org/10.3389/fphar.2024.1393636

2024-07-05

Abstract:Background: Gabon faced COVID-19 with more than 49,000 individuals tested positive and 307 recorded fatalities since the first reported case in 2020. A popular hypothesis is that the low rate of cases and deaths in the country was attributed to the use of medicinal plants in prevention and treatment. This study aimed to document the plants used for remedial and preventive therapies by the Gabonese population during the COVID-19 pandemic and to pinpoint specific potential plant species that merit further investigation. Methods: An ethnobotanical survey involving 97 participants was conducted in Libreville. Traditional healers and medicinal plant vendors were interviewed orally using a semi-structured questionnaire sheet, while the general population responded to an online questionnaire format. Various quantitative indexes were calculated from the collected data and included the relative frequency of citation (RFC), use value (UV), informant consensus factor (ICF), relative importance (RI), and popular therapeutic use value (POPUT). One-way ANOVA and independent samples t-test were used for statistical analyses. p-values ≤0.05 were considered significant. Results: The survey identified 63 plant species belonging to 35 families. Prevalent symptoms treated included fever (18%), cough (16%), fatigue (13%), and cold (12%). The demographic data highlighted that 52.58% of male subjects (p > 0.94) aged 31-44 years were enrolled in the survey, of which 48.45% (p < 0.0001) and 74.73% (p < 0.99) of informants had university-level education. In addition, the results indicated that a total of 66% of the informants used medicinal plants for prophylaxis (34%), for both prevention and treatment (26%), exclusively for treatment (3%), and only for prevention (3%) while suffering from COVID-19, against 34% of the participants who did not use plants for prevention or treatment. Annickia chlorantha, Citrus sp., Alstonia congensis, Zingiber officinale, and Carica papaya emerged as the most commonly cited plants with the highest RFC (0.15-0.26), UV (0.47-0.75), and RI (35.72-45.46) values. Most of these plants were used either individually or in combination with others. Conclusion: The survey reinforces the use of traditional medicine as a method to alleviate COVID-19 symptoms, thereby advocating for the utilization of medicinal plants in managing coronavirus infections.
Comparison study of Beninese and Chinese herbal medicines in treating COVID-19

Yi Wang,Qian Zhou,Han Zhang,Xiaoying Wang,Elisabeth A. Houeze

DOI: https://doi.org/10.1016/j.jep.2023.116172

IF: 5.195

2023-02-11

Journal of Ethnopharmacology

Abstract:Ethnopharmacological relevance The worldwide use of natural remedies is an alternative therapeutic solution to strengthen immunity, fight, and prevent this disease. The rapid spread of the coronavirus disease worldwide has promoted the search for therapeutic solutions following different approaches. China and Benin have seen the use of natural remedies such as Chinese herbal medicine and local endemic plants as alternative solutions in treating COVID-19. Aim of the study The present study was designed to identify the prevalence of medicinal plant use in four municipalities of Benin most affected by COVID -19 and compare them with traditional Chinese medicine and finally verify the efficacy of the main components of the six plants most frequently used, via in vitro experiments. Materials and methods This study targeting market herbalists and traditional healers was conducted in the form of an ethnomedicinal survey in four representative communities (Cotonou, Abomey-Calavi, Zè, and Ouidah) of southern Benin. The chemical compositions of the six most commonly used herbs were investigated using network pharmacology. Network-based global prediction of disease genes and drug, target, function, and pathway enrichment analysis of the top six herbs was conducted using databases including IPA and visualised using Cytoscape software. The natural botanical drugs involved three medicines and three formulas used in the treatment of COVID-19 in China from the published literature were compared with the top six botanical drugs used in Benin to identify similarities between them and guide the clinical medication in both countries. Finally, the efficacy of the common ingredients in six plants was verified by measuring the viability of BEAS-2B cells and the release of inflammatory factors after administration of different ingredients. Binding abilities of six components to COVID-19 related targets were verified by molecular docking. Results According to the medication survey investigation, the six most used herbs were Citrus aurantiifolia (13.18%), Momordica charantia (7.75%), Ocimum gratissimum (7.36%), Crateva adansonii (6.59%), Azadirachta indica (5.81%), and Zanthoxylum zanthoxyloides (5.42%). The most represented botanical families were Rutaceae , Lamiaceae , Cucurbitaceae , Meliaceae , and Capparaceae . The network pharmacology of these six herbal plants showed that the flavonoids quercetin, kaempferol, and β-sitosterol were the main active ingredients of the Benin herbal medicine. Chinese and Beninese herbal medicine are similar in that they have the same targets and pathways in inflammation and oxidative stress relief. Mild COVID-19-related targets come from C. aurantiifolia and M. charantia , and severe COVID-19-related targets come from A. indica A. Juss. Cell viability and enzyme-linked immunosorbent assay results confirmed that six major compounds could protect BEAS-2B cells against injury by inhibiting the expression of inflammatory factors, among which quercetin and isoimperatorin were more effective. Docking verified that the six compounds have good binding potential with COVID-19 related targets. Conclusions These results suggest that Benin herbal medicine and Chinese herbal medicine overlap in compounds, targets, and pathways to a certain extent. Among the commonly used plants in Benin, C. aurantiifolia and M. charantia may have a good curative effect on the treatment of mild COVID-19, while for severe COVID-19, A. indica can be added on this basis.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review

Bikash Adhikari,Bishnu P Marasini,Binod Rayamajhee,Bibek Raj Bhattarai,Ganesh Lamichhane,Karan Khadayat,Achyut Adhikari,Santosh Khanal,Niranjan Parajuli

DOI: https://doi.org/10.1002/ptr.6893

Abstract:The whole world is entangled by the coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), people are dying in thousands each day, and without an actual medication, it seems not possible for the bringing this global health crisis to a stop. Natural products have been in constant use since ancient times and are proven by time to be effective. Crude extract or pure compounds isolated from medicinal plants and/or herbs such as Artemisia annua, Agastache rugosa, Astragalus membranaceus, Cassia alata, Ecklonia cava, Gymnema sylvestre, Glycyrrhizae uralensis, Houttuynia cordata, Lindera aggregata, Lycoris radiata, Mollugo cerviana, Polygonum multiflorum, Pyrrosia lingua, Saposhnikoviae divaricate, Tinospora cordifolia etc. have shown promising inhibitory effect against coronavirus. Several molecules, including acacetin, amentoflavone, allicin, blancoxanthone, curcumin, daidzein, diosmin, epigallocatechin-gallate, emodin, hesperidin, herbacetin, hirsutenone, iguesterin, jubanine G, kaempferol, lycorine, pectolinarin, phloroeckol, silvestrol, tanshinone I, taxifolin, rhoifolin, xanthoangelol E, zingerol etc. isolated from plants could also be potential drug candidates against COVID-19. Moreover, these could also show promising inhibitory effects against influenza-parainfluenza viruses, respiratory syncytial virus, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome coronavirus (MERS-CoV). Here, we have reported 93 antiviral drug candidates which could be a potential area of research in drug discovery.
Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review

Hadi Al-Jamal,Sara Idriss,Rabih Roufayel,Ziad Abi Khattar,Ziad Fajloun,Jean-Marc Sabatier

DOI: https://doi.org/10.3390/v16030320

2024-02-21

Viruses

Abstract:In 2020, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) challenged the world with a global outbreak that led to millions of deaths worldwide. Coronavirus disease 2019 (COVID-19) is the symptomatic manifestation of this virus, which can range from flu-like symptoms to utter clinical complications and even death. Since there was no clear medicine that could tackle this infection or lower its complications with minimal adverse effects on the patients' health, the world health organization (WHO) developed awareness programs to lower the infection rate and limit the fast spread of this virus. Although vaccines have been developed as preventative tools, people still prefer going back to traditional herbal medicine, which provides remarkable health benefits that can either prevent the viral infection or limit the progression of severe symptoms through different mechanistic pathways with relatively insignificant side effects. This comprehensive review provides scientific evidence elucidating the effect of 10 different plants against SARS-CoV-2, paving the way for further studies to reconsider plant-based extracts, rich in bioactive compounds, into more advanced clinical assessments in order to identify their impact on patients suffering from COVID-19.

virology
The use of medicinal plants to prevent COVID-19 in Nepal

Dipak Khadka,Man Kumar Dhamala,Feifei Li,Prakash Chandra Aryal,Pappu Rana Magar,Sijar Bhatta,Manju Shree Thakur,Anup Basnet,Dafang Cui,Shi Shi

DOI: https://doi.org/10.1186/s13002-021-00449-w

2021-04-08

Abstract:Background: Medicinal plants are the fundamental unit of traditional medicine system in Nepal. Nepalese people are rich in traditional medicine especially in folk medicine (ethnomedicine), and this system is gaining much attention after 1995. The use of medicinal plants has increased during the COVID-19 pandemic as a private behavior (not under the control of government). A lot of misinterpretations of the use of medicinal plants to treat or prevent COVID-19 have been spreading throughout Nepal which need to be managed proactively. In this context, a research was needed to document medicinal plants used, their priority of use in society, their cultivation status, and the source of information people follow to use them. This study aimed to document the present status of medicinal plant use and make important suggestion to the concerned authorities. Methods: This study used a web-based survey to collect primary data related to medicinal plants used during COVID-19. A total of 774 respondents took part in the survey. The study calculated the relative frequencies of citation (RFC) for the recorded medicinal plants. The relationship between plants recorded and different covariates (age, gender education, occupation, living place, and treatment methods) was assessed using Kruskal-Wallis test and Wilcoxon test. The relationship between the information sources people follow and the respondent characteristics was assessed using chi-square test. Results: The study found that the use of medicinal plants has increased during COVID-19 and most of the respondents recommended medicinal plants to prevent COVID-19. This study recorded a total of 60 plants belonging to 36 families. The leaves of the plants were the most frequently used. The Zingiber officinale was the most cited species with the frequency of citation 0.398. Most of the people (45.61%) were getting medicinal plants from their home garden. The medicinal plants recorded were significantly associated with the education level, location of home, primary treatment mode, gender, and age class. The information source of plants was significantly associated with the education, gender, method of treatment, occupation, living with family, and location of home during the lockdown caused by COVID-19. Conclusions: People were using more medicinal plants during COVID-19 claiming that they can prevent or cure COVID-19. This should be taken seriously by concerned authorities. The authorities should test the validity of these medicinal plants and control the flow of false information spread through research and awareness programs.
Histochemistry and the structure of the skin of a murrel, Channa striata (Bloch, 1797) (Channiformes, Channidae). I. Epidermis.

A. Mittal,T. K. Banerjee

DOI: https://doi.org/10.1139/Z75-097

1975-06-01

Canadian Journal of Zoology

Abstract:The functional organization and cytochemistry of the epidermis of an air-breathing fish, Channa striata, is described. In the basal cells a dense population of mitochondria, strong alkaline phosphatase, and succinic dehydrogenase activity indicates high metabolic activity. In the outermost layer, polygonal cells showed strong succinic dehydrogenase activity and elaborated sulfated acid mucopolysaccharides and lipids. Mucous cells were also numerous. A new term, 'sacciform granulated cells,' is proposed for the 'sacciform cells' or 'granular cells.' The contents of these cells are basic proteins. A thick coat of slime containing mucopolysaccharides, lipids, and basic proteins is probably important in keeping the skin moist for cutaneous respiration, retarding the rate of water loss by evaporation, facilitating burrowing in the mud and swimming movement in water, and protecting the skin from bacterial and fungal attacks. A relatively thin epidermis (32 μm on the general surface, 18 μm at the posterior free ...
Ayurvedic and Chinese Herbs against Coronaviruses

Amin Gasmi,Sonia Kanwal,Petro Oliinyk,Roman Lysiuk,Mariia Shanaida,Asma Gasmi Benahmed,Walallawita Kankanamge Tharindu Dushmantha,Maria Arshad,Ivanna Kernychna,Larysa Lenchyk,Taras Upyr,Volodymyr Shanaida,Geir Bjørklund

DOI: https://doi.org/10.2174/0113816128269864231112094917

Abstract:Coronavirus disease 2019 (COVID-19) is a viral disease that infects the lower airways, causing severe acute respiratory syndrome (SARS) and fatal pneumonia. The ripple effect of the COVID-19 outbreak has created serious problems in the healthcare systems of many countries and had far-reaching consequences for the global economy. Thus, effective control measures should be implemented for this coronavirus infection in the future. The ongoing episode of the SARS-CoV-2 sickness, COVID-19, in China, and the subsequent irregular spread of contamination to different nations, has alarmed the clinical and academic community primarily due to the deadly nature of this disease. Being a newly identified virus in the viral classification and having the highest mutation rate, rapid therapeutics are not readily available for treating this ailment, leading to the widespread of the disease and causing social issues for affected individuals. Evidence of Ayurveda and traditional Chinese medicine (TCM) has been found in ancient civilizations, such as those of the Hindus, Babylonians, Hebrews, and Arabs. Although TCM and Ayurvedic herbs do not promise to be very effective treatments for this pandemic, they can reduce infectivity and virulence by enhancing immunity and showing effectiveness in rehabilitation after COVID-19 disease. Thus, they could be used as sources of inhibitor molecules for certain phenomena, such as viral replication, attachment to the host, 3CL protease inhibition, 3a ion channel inhibitors, and reverse transcription inhibition. Medicinal plants from TCM and Ayurveda and their biologically active phytoconstituents can effectively modulate the targets and pathways relevant to inflammation and immune responses in human bodies. The present review analyzes the role of certain TCM and Ayurvedic medicinal plants in healing COVID-19 infection. Medicinal plants such as Glycyrrhiza glabra (licorice), Curcuma longa (turmeric), and Zingiber officinale (ginger) are regarded as the main antiviral herbs. Their extracts and individual bioactive compounds could be used as potential substances for developing remedies to prevent or cure the coronavirus disease. Generally, antiviral phytochemicals obtained from natural sources are considered potent candidates for fighting COVID-19 infection and rehabilitation after it.
Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment

Shabana Bibi,Ayesha Sarfraz,Ghazala Mustafa,Zeeshan Ahmad,Muhammad A Zeb,Yuan-Bing Wang,Tahir Khan,Muhammad S Khan,Mohammad A Kamal,Hong Yu,Muhammad A. Zeb,Muhammad S. Khan,Mohammad A. Kamal

DOI: https://doi.org/10.2174/1381612826666201118103416

IF: 3.31

2021-04-23

Current Pharmaceutical Design

Abstract:Background: Coronavirus Disease-2019 belongs to the family of viruses which cause serious pneumonia along with fever, breathing issues and infection of lungs, and was first reported in China and later spread worldwide. Objective: Several studies and clinical trials have been conducted to identify potential drugs and vaccines for Coronavirus Disease-2019. The present study listed natural secondary metabolites identified from plant sources with antiviral properties and could be a safer and tolerable treatment for Coronavirus Disease-2019. Methods: A comprehensive search on the reported studies was conducted using different search engines such as Google Scholar, SciFinder, Sciencedirect, Medline PubMed, and Scopus for the collection of research articles based on plant-derived secondary metabolites, herbal extracts, and traditional medicine for coronavirus infections. Results: Status of COVID-19 worldwide and information of important molecular targets involved in COVID- 19 are described, and through literature search, it is highlighted that numerous plant species and their extracts possess antiviral properties and are studied with respect to coronavirus treatments. Chemical information, plant source, test system type with a mechanism of action for each secondary metabolite are also mentioned in this review paper. Conclusion: The present review has listed plants that have presented antiviral potential in the previous coronavirus pandemics and their secondary metabolites, which could be significant for the development of novel and a safer drug which could prevent and cure coronavirus infection worldwide.

pharmacology & pharmacy
In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection

Mansi Pandit,N. Latha

DOI: https://doi.org/10.21203/rs.3.rs-22687/v1

2020-04-14

Abstract:Abstract The spread of COVID-19 across continents has led to a global health emergency. COVID-19 disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected nearly all the continents with around 1.52 million confirmed cases worldwide. Currently only a few regimes have been suggested to fight the infection and no specific antiviral agent or vaccine is available. Repurposing of the existing drugs or use of natural products are the fastest options available for the treatment. The present study is aimed at employing computational approaches to screen phytochemicals from the medicinal plants targeting the proteins of SARS-CoV2 for identification of antiviral therapeutics. The study focuses on three target proteins important in the life cycle of SARS-CoV-2 namely Spike (S) glycoprotein, main protease (Mpro) and RNA-dependent RNA-polymerase (RdRp). Molecular docking was performed to screen phytochemicals in medicinal plants to determine their feasibility as potential inhibitors of these target viral proteins. Of the 30 plant phytochemicals screened, Silybin, an active constituent found in Silybum marianum exhibited higher binding affinity with targets in SARS-CoV-2 in comparison to currently used repurposed drugs against SARS-CoV-2. Withaferin A from Withania somnifera also showed significant binding to the targets proteins. In addition, phytochemicals from Tinospora cordiofolia and Aloe barbadensis displayed good binding energetics with the target proteins in SARS-CoV-2. These results provide a basis for the use of traditional medicinal plants as alternative lines of treatment for COVID-19 infection.
Phytoconstituents Profiling of Indigenous Herbal Drugs and Its in vitro Microbial, in Silico Biological Examination against Severe Acute Respiratory Syndrome Coronavirus 2

T. H. Mohamed Ahadu Shareef,M. Mohamed Divan Masood,Irfan Navabshan,M. Saiyad Musthafa

DOI: https://doi.org/10.4103/wjtcm.wjtcm_37_23

2024-01-01

World Journal of Traditional Chinese Medicine

Abstract:Abstract Background: Habb-E-Shifa , Hamdard Sualin , and Hamdard Joshanda traditional herbal medicines may promote host resistance against infection by bacteria, viruses, and fungi which are easily accessible at inexpensive with no complexity. These herbal medicines are used to cure sore throat, cough, fever, lung cancer, and asthma patients in developing South Asian countries. These traditional herbal medicines acted a crucial role in the prevention and control of coronavirus disease 2019 (COVID-19). Aims and Objectives: This research article aimed at conducting phytochemistry, antimicrobial activity, COVID-19 docking and some spectroscopic (Infrared, Ultraviolet, 13 C-Nuclear Magnetic Resonance ( 13 C-NMR), 1 H-NMR, and Mass Spectra) characterizations of the polyherbal drugs were carried out. Additionally, In-vitro and In-silico analyses were performed to measure activity against COVID-19. High Performance - Liquid Chromatography (HPLC), Gas Chromatography - Mass Spectrometry (GC-MS), antimicrobial, and docking studies were carried out. The preliminary phytochemical assay and bioactive compounds were screened using HPLC and GC-MS. The study is an attempt to assess the promising effects of selected polyherbal indigenous drugs such as Habb-E-Shifa , Hamdard Sualin , and Hamdard Joshanda phytoconstituents against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Materials and Methods: The extract of the selected polyherbal formulations showed high-to-moderate preventive effects on the growth inhibition in the pathogenic bacterium, namely Streptococcus oralis , Staphylococcus aureus , Propionibacterium acnes , Pseudomonas aeruginosa , Escherichia coli , and Proteus vulgaris , and three fungal Candida albicans, Aspergillus fumigatus , and Aspergillus niger . Further docking study evaluates the pharmacological activity of bioactive chemical compounds with SARS-CoV-2 NSP5 (PDB ID: 7nxh) and SARS-CoV-2 Omicron spike protein with human angiotensin-converting enzyme 2 (ACE-2) (PDB ID: 7wk6). Results: In this study, for the first time, we attempted to examine some spectroscopic characterization of selected herbals. The total phenol content (1.66, 1.55, and 1.13 mg/mL) and total flavonoid content (4.92, 0.49, and 0.50 mg/mL) were present in the extracted samples of Habb-E-Shifa ( H ), Hamdard Joshanda ( J ), and Hamdard Sualin ( S ). Studies on COVID-19 docking infer the affinity of the herb’s chemical components toward COVID-19 protease and ACE-2 receptor by establishing excellent binding capacity in complex formation. The results confirmed that polyherbal drugs harbor biological activities and thereby highlight that these extracts can serve as a remedy for antimicrobial and COVID-19. Conclusions: The research article confirms the remarkable potential in exhibiting antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. These herbal medicines such as Habb-E-Shifa (H) , Hamdard Joshanda (J) , and Hamdard Sualin ( S ) showed a vital role against SARS-CoV-2 Omicron spike protein with human ACE2 (7wk6) and amino acids of SARS-CoV-2 NSP5 (7nxh). Our study provides obvious evidence supporting dietary therapy and herbal medicine as potentially effective against SARS-CoV-2. Based on present studies, these herbal products can be introduced as preventive and therapeutic agents fight against coronavirus.

pharmacology & pharmacy,medicine, research & experimental,integrative & complementary medicine
Plant‐derived compounds as potential leads for new drug development targeting COVID‐19

Lingxiu Liu,Maxim Kapralov,Mark Ashton

DOI: https://doi.org/10.1002/ptr.8105

IF: 6.388

2024-01-30

Phytotherapy Research

Abstract:COVID‐19, which was first identified in 2019 in Wuhan, China, is a respiratory illness caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Although some patients infected with COVID‐19 can remain asymptomatic, most experience a range of symptoms that can be mild to severe. Common symptoms include fever, cough, shortness of breath, fatigue, loss of taste or smell and muscle aches. In severe cases, complications can arise including pneumonia, acute respiratory distress syndrome, organ failure and even death, particularly in older adults or individuals with underlying health conditions. Treatments for COVID‐19 include remdesivir, which has been authorised for emergency use in some countries, and dexamethasone, a corticosteroid used to reduce inflammation in severe cases. Biological drugs including monoclonal antibodies, such as casirivimab and imdevimab, have also been authorised for emergency use in certain situations. While these treatments have improved the outcome for many patients, there is still an urgent need for new treatments. Medicinal plants have long served as a valuable source of new drug leads and may serve as a valuable resource in the development of COVID‐19 treatments due to their broad‐spectrum antiviral activity. To date, various medicinal plant extracts have been studied for their cellular and molecular interactions, with some demonstrating anti‐SARS‐CoV‐2 activity in vitro. This review explores the evaluation and potential therapeutic applications of these plants against SARS‐CoV‐2. This review summarises the latest evidence on the activity of different plant extracts and their isolated bioactive compounds against SARS‐CoV‐2, with a focus on the application of plant‐derived compounds in animal models and in human studies.

pharmacology & pharmacy,chemistry, medicinal
Edible and Herbal Plants for the Prevention and Management of COVID-19

Sha Li,Chien-Shan Cheng,Cheng Zhang,Guo-Yi Tang,Hor-Yue Tan,Hai-Yong Chen,Ning Wang,Agnes Yuen-Kwan Lai,Yibin Feng

DOI: https://doi.org/10.3389/fphar.2021.656103

IF: 5.6

2021-04-28

Frontiers in Pharmacology

Abstract:Background: The outbreak of the pandemic coronavirus disease 2019 (COVID-19) has now become a global pandemic spreading throughout the world. Unfortunately, due to the high infectiousness of the novel β -coronavirus, it is very likely to become an ordinary epidemic. The development of dietary supplements and functional foods might provide a strategy for the prevention and management of COVID-19. Scope and Approach: A great diversity of potential edible and medicinal plants and/or natural compounds showed potential benefits in managing SARS, which may also combat COVID-19. Moreover, many plants and compounds have currently been proposed to be protective against COVID-19. This information is based on data-driven approaches and computational chemical biology techniques. In this study, we review promising candidates of edible and medicinal plants for the prevention and management of COVID-19. We primarily focus on analyzing their underlying mechanisms. We aim to identify dietary supplements and functional foods that assist in managing this epidemic. Key findings and Conclusion: We infer that acetoside, glyasperin, isorhamnetin, and several flavonoid compounds may prevent and/or be effective in managing COVID-19 by targeting the viral infection, reducing the host cytokine storm, regulating the immune response, and providing organ protection. These bioactive dietary components (used either alone or in combination) might assist in the development of dietary supplements or functional foods for managing COVID-19.

pharmacology & pharmacy
Potential of traditional medicines in alleviating COVID-19 symptoms

Moragot Chatatikun,Hiroko P Indo,Motoki Imai,Fumitaka Kawakami,Makoto Kubo,Yoshimasa Kitagawa,Hiroshi Ichikawa,Lunla Udomwech,Atthaphong Phongphithakchai,Orawan Sarakul,Suriyan Sukati,Voravuth Somsak,Takafumi Ichikawa,Wiyada Kwanhian Klangbud,Veeranoot Nissapatorn,Jitbanjong Tangpong,Hideyuki J Majima

DOI: https://doi.org/10.3389/fphar.2024.1452616

2024-09-26

Abstract:This review discusses the prevention and treatment of coronavirus disease 2019 (COVID-19) caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Mutations in its spike glycoprotein have driven the emergence of variants with high transmissibility and immune escape capabilities. Some antiviral drugs are ineffective against the BA.2 subvariant at the authorized dose. Recently, 150 natural metabolites have been identified as potential candidates for development of new anti-COVID-19 drugs with higher efficacy and lower toxicity than those of existing therapeutic agents. Botanical drug-derived bioactive molecules have shown promise in dampening the COVID-19 cytokine storm and thus preventing pulmonary fibrosis, as they exert a strong binding affinity for viral proteins and inhibit their activity. The Health Ministry of Thailand has approved Andrographis paniculata (Jap. Senshinren) extracts to treat COVID-19. In China, over 85% of patients infected with SARS-CoV-2 receive treatments based on traditional Chinese medicine. A comprehensive map of the stages and pathogenetic mechanisms related to the disease and effective natural products to treat and prevent COVID-19 are presented. Approximately 10% of patients with COVID-19 are affected by long COVID, and COVID-19 infection impairs mitochondrial DNA. As the number of agents to treat COVID-19 is limited, adjuvant botanical drug treatments including vitamin C and E supplementation may reduce COVID-19 symptoms and inhibit progression to long COVID.
Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies

Akalesh Kumar Verma,Vikas Kumar,Sweta Singh,Bhabesh Ch Goswami,Ihosvany Camps,Aishwarya Sekar,Sanghwa Yoon,Keun Woo Lee,Bhabesh Ch. Goswami

DOI: https://doi.org/10.1016/j.biopha.2021.111356

2021-05-01

Abstract:All the plants and their secondary metabolites used in the present study were obtained from Ayurveda, with historical roots in the Indian subcontinent. The selected secondary metabolites have been experimentally validated and reported as potent antiviral agents against genetically-close human viruses. The plants have also been used as a folk medicine to treat cold, cough, asthma, bronchitis, and severe acute respiratory syndrome in India and across the globe since time immemorial. The present study aimed to assess the repurposing possibility of potent antiviral compounds with SARS-CoV-2 target proteins and also with host-specific receptor and activator protease that facilitates the viral entry into the host body. Molecular docking (MDc) was performed to study molecular affinities of antiviral compounds with aforesaid target proteins. The top-scoring conformations identified through docking analysis were further validated by 100 ns molecular dynamic (MD) simulation run. The stability of the conformation was studied in detail by investigating the binding free energy using MM-PBSA method. Finally, the binding affinities of all the compounds were also compared with a reference ligand, remdesivir, against the target protein RdRp. Additionally, pharmacophore features, 3D structure alignment of potent compounds and Bayesian machine learning model were also used to support the MDc and MD simulation. Overall, the study emphasized that curcumin possesses a strong binding ability with host-specific receptors, furin and ACE2. In contrast, gingerol has shown strong interactions with spike protein, and RdRp and quercetin with main protease (Mpro) of SARS-CoV-2. In fact, all these target proteins play an essential role in mediating viral replication, and therefore, compounds targeting aforesaid target proteins are expected to block the viral replication and transcription. Overall, gingerol, curcumin and quercetin own multitarget binding ability that can be used alone or in combination to enhance therapeutic efficacy against COVID-19. The obtained results encourage further in vitro and in vivo investigations and also support the traditional use of antiviral plants preventively.

pharmacology & pharmacy,medicine, research & experimental
On the Inhibition of COVID-19 Protease by Indian Herbal Plants: An In Silico Investigation

Ambrish Kumar Srivastava,Abhishek Kumar,Neeraj Misra

DOI: https://doi.org/10.48550/arXiv.2004.03411

2020-04-05

Other Quantitative Biology

Abstract:COVID-19 has quickly spread across the globe, becoming a pandemic. This disease has a variable impact in different countries depending on their cultural norms, mitigation efforts and health infrastructure. In India, a majority of people rely upon traditional Indian medicine to treat human maladies due to less-cost, easier availability and without any side-effect. These medicines are made by herbal plants. This study aims to assess the Indian herbal plants in the pursuit of potential COVID-19 inhibitors using in silico approaches. We have considered 18 extracted compounds of 11 different species of these plants. Our calculated lipophilicity, aqueous solubility and binding affinity of the extracted compounds suggest that the inhibition potentials in the order; harsingar > aloe vera > giloy > turmeric > neem > ashwagandha > red onion > tulsi > cannabis > black pepper. On comparing the binding affinity with hydroxychloroquine, we note that the inhibition potentials of the extracts of harsingar, aloe vera and giloy are very promising. Therefore, we believe that these findings will open further possibilities and accelerate the works towards finding an antidote for this malady.
Food as medicine: A possible preventive measure against coronavirus disease ( COVID ‐19)

Fan Yang,Yue Zhang,Akash Tariq,Xiaolan Jiang,Zeeshan Ahmed,Zhang Zhihao,Muhammad Idrees,Azizullah Azizullah,Muhammad Adnan,Rainer W. Bussmann

DOI: https://doi.org/10.1002/ptr.6770

IF: 6.388

2020-07-21

Phytotherapy Research

Abstract:The recent and ongoing outbreak of coronavirus disease (COVID‐19) is a huge global challenge. The outbreak, which first occurred in Wuhan City, Hubei Province, China and then rapidly spread to other provinces and to more than 200 countries abroad, has been declared a global pandemic by the World Health Organization (WHO). Those with compromised immune systems and/or existing respiratory, metabolic or cardiac problems are more susceptible to the infection and are at higher risk of serious illness or even death. The present review was designed to report important functional food plants with immunomodulatory and anti‐viral properties. Data on medicinal food plants was retrieved and downloaded from English‐language journals using online search engines. The functional food plants herein documented might not only enhance the immune system and cure respiratory tract infections but can also greatly impact the overall health of the general public. As many people in the world are now confined to their homes, inclusion of these easily accessible plants in the daily diet may help to strengthen the immune system and guard against infection by SARS‐CoV‐2. This might reduce the risk of COVID‐19 and initiate a rapid recovery in cases of SARS‐CoV‐2 infection.This article is protected by copyright. All rights reserved.

pharmacology & pharmacy,chemistry, medicinal
Serum sex-hormone binding globulin and mortality risk in postmenopausal women.

P. Lundberg,G. Lindstedt,L. Lapidus,C. Bengtsson

DOI: https://doi.org/10.1093/CLINCHEM/31.4.654

IF: 12.114

1985-04-01

Clinical Chemistry

Abstract:

Routine symptom assessment: good for practice and good for business

An Insight into COVID-19 and Traditional Herbs: Bangladesh Perspective

Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research

Exploration of medicinal plants as potential therapeutics against COVID-19: molecular insights and drug development prospects with other significant medicinal information a retrospective exposition

Medicinal plants used in Gabon for prophylaxis and treatment against COVID-19-related symptoms: an ethnobotanical survey

Comparison study of Beninese and Chinese herbal medicines in treating COVID-19

Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review

Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review

The use of medicinal plants to prevent COVID-19 in Nepal

Histochemistry and the structure of the skin of a murrel, Channa striata (Bloch, 1797) (Channiformes, Channidae). I. Epidermis.

Ayurvedic and Chinese Herbs against Coronaviruses

Impact of Traditional Plants and their Secondary Metabolites in the Discovery of COVID-19 Treatment

In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection

Phytoconstituents Profiling of Indigenous Herbal Drugs and Its in vitro Microbial, in Silico Biological Examination against Severe Acute Respiratory Syndrome Coronavirus 2

Plant‐derived compounds as potential leads for new drug development targeting COVID‐19

Edible and Herbal Plants for the Prevention and Management of COVID-19

Potential of traditional medicines in alleviating COVID-19 symptoms

Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies

On the Inhibition of COVID-19 Protease by Indian Herbal Plants: An In Silico Investigation

Food as medicine: A possible preventive measure against coronavirus disease ( COVID ‐19)

Serum sex-hormone binding globulin and mortality risk in postmenopausal women.